OTCM
BABYF
Market cap205kUSD
Oct 08, Last price
0.05USD
1D
-6.78%
1Q
98.00%
IPO
-98.70%
Name
Else Nutrition Holdings Inc
Chart & performance
P/E
—
P/S
0.05
EPS
—
Div yield, %
—
Shrs. gr., 5y
-15.89%
Rev. gr., 5y
32.38%
Revenues
6m
-24.43%
Net income
-9m
L-41.51%
CFO
-3m
L-64.85%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Else Nutrition Holdings Inc. focuses on the creation, production, and distribution of a variety of food and nutritional items for consumers ranging from infants and toddlers to children and adults. The company primarily operates within the North American and Israeli markets. Their product line encompasses plant-based baby formula, infant snacks, essential baby feeding accessories (including bottles and teats), as well as dedicated nutrition products for toddlers, children, and adults, alongside various supplementary food offerings. Customers can also purchase these products through online sales channels. The company's main office is located in Tel Aviv-Yafo, Israel.
Key people
Fabiana Bar-Yoseph
Director of Clinical Development · since 2019
Barak Orenstein
Director of Digital Marketing · since 2019
Asher Waidberg
Head of Product Development · since 2019
Terry Tang
President, Chief Executive Officer, Corporate Secretary, Director
Manuel Gomez
Director · since 2017
Director · since 2017
Ramon Perez
Director · since 2015
Sokhie Puar
Director · since 2015
Eli Ronen
Director · since 2019
Legal address
1200 - 750 West Pender St.
Vancouver, BC V6C 2T8
CA
Vancouver, BC V6C 2T8
CA
Headquarters
24 Raul Wallenberg
Tel Aviv 69710
IL
Tel Aviv 69710
IL
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||